Bispecific Antibodies in Prostate Cancer Therapy: Current Status and Perspectives.

Heitmann, Jonas S; Pfluegler, Martin; Jung, Gundram; Salih, Helmut R

Heitmann, Jonas S; Pfluegler, Martin; Jung, Gundram; Salih, Helmut R.

Afiliación

Heitmann JS; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.
Pfluegler M; DFG Cluster of Excellence 2180 "Image-Guided and Functional Instructed Tumor Therapy" (IFIT), University of Tübingen, 72076 Tübingen, Germany.
Jung G; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.
Salih HR; DFG Cluster of Excellence 2180 "Image-Guided and Functional Instructed Tumor Therapy" (IFIT), University of Tübingen, 72076 Tübingen, Germany.

Cancers (Basel) ; 13(3)2021 Feb 01.

Article en En | MEDLINE | ID: mdl-33535627

Palabras clave

CRPC; bispecific antibody; prostate cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google